B. Blechacz and L. Mishra, Hepatocellular Carcinoma Biology, pp.1-20
DOI : 10.1007/978-3-642-16037-0_1

H. El-serag, Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma, Gastroenterology, vol.142, issue.6, pp.1264-1273
DOI : 10.1053/j.gastro.2011.12.061

N. Nishida and M. Kudo, Recent advancements in comprehensive genetic analysis for human hepatocellular carcinoma, Oncology, vol.2013, issue.84 1, pp.93-97

J. Ogunbiyi, Hepatocellular carcinoma in the developing world, Seminars in Oncology, vol.28, issue.2, pp.179-187, 2001.
DOI : 10.1016/S0093-7754(01)90090-9

A. Benouda, Z. Boujdiya, S. Ahid, R. Abouqal, and M. Adnaoui, Pr??valence de l???infection par le virus de l???h??patite-C au Maroc et ??valuation des tests s??rologiques de d??pistage pour la pr??diction de la vir??mie, Pathologie Biologie, vol.57, issue.5, pp.368-372, 2009.
DOI : 10.1016/j.patbio.2008.07.006

P. Cacoub, V. Ohayon, S. Sekkat, B. Dumont, A. Sbai et al., Etude épidémiologique et virologique des infections par le virus de l'hépatite C au Maroc, Gastroenterol Clin Biol, vol.24, pp.169-173, 2000.

S. Ezzikouri, P. Pineau, and S. Benjelloun, Hepatitis B virus in the Maghreb Region: from epidemiology to prospective research, Liver International, vol.12, issue.1, pp.811-819, 2013.
DOI : 10.1111/liv.12135

URL : https://hal.archives-ouvertes.fr/pasteur-00820371

N. Tahani, H. Serghini-caid, M. Ouzouline, and A. Elamrani, Mycologie du blé tendre : qualité technologique du grain et conséquences sur les produits finis, Rev Biol Biotech, vol.7, pp.27-32, 2008.

A. Zinedine, C. Juan, J. Soriano, J. Molto, L. Idrissi et al., Limited survey for the occurrence of aflatoxins in cereals and poultry feeds from Rabat, Morocco, International Journal of Food Microbiology, vol.115, issue.1, pp.124-127, 2007.
DOI : 10.1016/j.ijfoodmicro.2006.10.013

F. Jin, W. Xiong, J. Jing, Z. Feng, L. Qu et al., Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review, Journal of Cancer Research and Clinical Oncology, vol.28, issue.2, pp.1095-1104, 2011.
DOI : 10.1007/s00432-010-0970-0

P. Nahon and J. Zucman-rossi, Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis, Journal of Hepatology, vol.57, issue.3, pp.663-674, 2012.
DOI : 10.1016/j.jhep.2012.02.035

H. Van-malenstein, J. Van-pelt, and C. Verslype, Molecular classification of hepatocellular carcinoma anno 2011, European Journal of Cancer, vol.47, issue.12, pp.1789-1797, 2011.
DOI : 10.1016/j.ejca.2011.04.027

S. Ezzikouri, E. Feydi, A. Afifi, R. Elkihal, L. Benazzouz et al., MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: A case???control analysis in a Moroccan population, Cancer Detection and Prevention, vol.32, issue.5-6, pp.2380-385, 2009.
DOI : 10.1016/j.cdp.2009.01.003

G. Bond, W. Hu, E. Bond, H. Robins, S. Lutzker et al., A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans, Cell, vol.119, issue.5, pp.591-602, 2004.
DOI : 10.1016/j.cell.2004.11.022

G. Bond and A. Levine, A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans, Oncogene, vol.53, issue.9, pp.1317-1323, 2007.
DOI : 10.1002/humu.20277

H. Ma, T. Huang, F. Han, and W. Chen, Association Between MDM2 Promoter SNP309 T/G Polymorphism and Liver Cancer Risk - a Meta-analysis, Asian Pacific Journal of Cancer Prevention, vol.13, issue.6, pp.2841-2846, 2012.
DOI : 10.7314/APJCP.2012.13.6.2841

S. Knappskog, L. Gansmo, P. Romundstad, M. Bjørnslett, J. Trovik et al., MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk, MDM2 Promoter SNP344T > a (rs1196333) status does Not affect cancer risk, pp.36263-36263, 2012.
DOI : 10.1371/journal.pone.0036263.t003

F. Paulin, O. Neil, M. Mcgregor, G. Cassidy, A. Ashfield et al., MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism, BMC Cancer, vol.44, issue.1, pp.281-291, 2008.
DOI : 10.1136/jmg.2006.042572

L. Excoffier, G. Laval, and S. Schneider, Arlequin ver. 3.0: An integrated software package for population genetics data analysis, Evol Bioinform Online, vol.1, pp.47-50, 2005.

X. Wang and X. Jiang, Mdm2 and MdmX partner to regulate p53, FEBS Letters, vol.133, issue.10, pp.1390-1396, 2012.
DOI : 10.1016/j.febslet.2012.02.049

S. Knappskog, M. Bjørnslett, L. Myklebust, P. Huijts, M. Vreeswijk et al., The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians, Cancer Cell, vol.19, issue.2, pp.273-282, 2010.
DOI : 10.1016/j.ccr.2010.12.019

S. Knappskog and P. Lønning, MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk, Oncotarget, vol.2, issue.3, pp.251-258, 2011.
DOI : 10.18632/oncotarget.243

P. Pineau, S. Ezzikouri, A. Marchio, M. Benazzouz, E. Cordina et al., Genomic stability prevails in North-African hepatocellular carcinomas. Dig Liver Dis, pp.671-677, 2007.
DOI : 10.1016/j.dld.2007.03.012

J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, International Journal of Cancer, vol.8, issue.19, pp.2893-2917, 2010.
DOI : 10.1002/ijc.25516

D. Lavanchy, Evolving epidemiology of hepatitis C virus, Clinical Microbiology and Infection, vol.17, issue.2, pp.107-115, 2011.
DOI : 10.1111/j.1469-0691.2010.03432.x

E. Esteban, N. Rodon, M. Via, E. Gonzalez-perez, J. Santamaria et al., Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships, Journal of Human Genetics, vol.62, issue.2, pp.129-136, 2006.
DOI : 10.1007/s10038-005-0336-7

E. Gonzalez-perez, M. Via, E. Esteban, A. López-alomar, S. Mazieres et al., Alu insertions in the Iberian Peninsula and North West Africa-genetic boundaries or melting pot? Coll Anthropol, pp.491-500, 2003.